xanthone has been researched along with Benign Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Arfuso, F; Banik, K; Bordoloi, D; Harsha, C; Kumar, AP; Kunnumakkara, AB; Lalduhsaki Sailo, B; Leong, HC; Mishra, S; Sethi, G; Wang, L | 1 |
| Butler, JR; Ready, JM; Wang, C; Wang, Y | 1 |
| Chen, XH; Feng, GK; Huang, L; Lan, WJ; Li, HJ; Qian, XJ; Xu, Z; Zhu, XF | 1 |
| Shen, R; Wang, W; Yang, G | 1 |
| Arumugasamy, K; Ata, A; Chandraprakash, K; Mohan, PS; Sankaran, M; Uvarani, C | 1 |
| Shen, R; Tang, N; Wang, HF | 1 |
| Hennink, WE; Khonkarn, R; Mankhetkorn, S; Okonogi, S; Talelli, M | 1 |
2 review(s) available for xanthone and Benign Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Therapeutic potential of gambogic acid, a caged xanthone, to target cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Garcinia; Humans; Models, Biological; Molecular Structure; Neoplasms; Xanthones | 2018 |
6 other study(ies) available for xanthone and Benign Neoplasms
| Article | Year |
|---|---|
Dehydrogenative coupling to enable the enantioselective total synthesis of (-)-simaomicin α.
Topics: Actinomycetaceae; Antineoplastic Agents; Antiparasitic Agents; Biological Products; Cell Line, Tumor; Humans; Hydrogenation; Isoquinolines; Neoplasms; Stereoisomerism; Xanthones | 2013 |
Cytotoxic prenylated xanthones from the pericarps of Garcinia mangostana.
Topics: Cell Line, Tumor; Drug Screening Assays, Antitumor; Fruit; Garcinia mangostana; Humans; Molecular Structure; Neoplasms; Plant Extracts; Xanthones | 2014 |
DNA binding property and antitumor evaluation of xanthone with dimethylamine side chain.
Topics: Binding, Competitive; Cell Proliferation; Circular Dichroism; Dimethylamines; DNA; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms; Spectrometry, Fluorescence; Tumor Cells, Cultured; Xanthones | 2014 |
A new DNA-intercalative cytotoxic allylic xanthone from Swertia corymbosa.
Topics: alpha-Glucosidases; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Cattle; Cell Line, Tumor; DNA; Glycoside Hydrolase Inhibitors; Humans; Intercalating Agents; Mice; Neoplasms; NIH 3T3 Cells; Plant Extracts; Swertia; Xanthones | 2015 |
Synthesis and characterization of the Zn(II) and Cu(II) piperidinyl isoeuxanthone complexes: DNA-binding and cytotoxic activity.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cattle; Cell Line, Tumor; Cell Survival; Copper; DNA; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Humans; Lung Neoplasms; Neoplasms; Spectroscopy, Near-Infrared; Stomach Neoplasms; Viscosity; Xanthones; Zinc | 2009 |
Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cytostatic Agents; Doxorubicin; Drug Carriers; Drug Compounding; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Kinetics; Leukocytes, Mononuclear; Micelles; Neoplasms; Particle Size; Polyethylene Glycols; Polymethacrylic Acids; Propidium; Solubility; Xanthones | 2012 |